Erythritol belongs chemically to the family of polyols (or sugar alcohols), yet it is metabolized by animals and humans very differently compared to all other polyols. While polyols have been used traditionally (for about 80 y) to replace sugar in sweet foods to reduce demineralization of tooth enamel and to reduce postprandial blood glucose levels, benefits achieved merely through the absence of sugar, emerging evidence shows that erythritol can play a number of functional roles to actively support maintenance of oral and systemic health. Oral health studies revealed that erythritol can reduce dental plaque weight, reduce dental plaque acids, reduce counts of mutans streptococci in saliva and dental plaque, and reduce the risk for dental caries better than sorbitol and xylitol, resulting in fewer tooth restorations by dentist intervention. Systemic health studies have shown that erythritol, unlike other polyols, is readily absorbed from the small intestine, not systemically metabolized, and excreted unchanged within the urine. This metabolic profile renders erythritol to be noncaloric, to have a high gastrointestinal tolerance, and not to increase blood glucose or insulin levels. Published evidence also shows that erythritol can act as an antioxidant and that it may improve endothelial function in people with type 2 diabetes. This article reviews the key research demonstrating erythritol's oral and systemic health functionalities and underlying mechanisms.
Introduction
Excessive intake of added sugars is increasingly associated with health issues, including dental caries, obesity, diabetes, and cardiovascular disease (World Health Organization [WHO] 2015) . This encouraged food scientists to develop alternative solutions that allow reduction or replacement of sugar, preferably without compromising taste. Ingredients used for such solutions are versatile and include polyols. The newest polyol is erythritol (de Cock 2012), a white, crystalline powder with similar crystal appearance, bulk density, and sweetness quality of sugar (sucrose). It occurs naturally in many fruits and fermented foods (Bernt et al. 1996) and is produced by a natural fermentation process using a carbohydrate feedstock sourced from renewable resources. Animal and human studies have consistently demonstrated the safety of erythritol as confirmed by the Joint WHO/FAO Expert Committee on Food Safety (JECFA 1999) and Food Safety Authorities in more than 60 countries around the world.
Erythritol has oral health benefits that go beyond the mere replacement of sugar, as discussed in a recent review (de Cock et al. 2016) . This review adds new data relating to differences in the oral microbiome following a 3-y intervention with erythritol, sorbitol, and xylitol. In addition, important systemic health roles of erythritol are discussed. Several systematic reviews and meta-analyses have pointed to the importance of the oral-systemic health link, showing that periodontal disease and its treatment are linked to multiple cardiovascular biomarkers and atherosclerotic disease outcomes, including endothelial function, hypertension, and glycemic control, especially in those already with diabetes (Teeuw et al. 2010; D'Aiuto et al. 2013; Leong et al. 2014; Orlandi et al. 2014; Teeuw et al. 2014) . Emerging evidence shows that erythritol, due to its unique metabolic behavior, also has systemic health potential in that same subpopulation of people at risk or suffering from diabetes.
Oral Health Functionality of Erythritol
Noncariogenicity of erythritol was established as far back as 1992 (Kawanabe et al. 1992) , after which it took more than a decade before studies were done to investigate the potential for erythritol to play an active role in improving oral health in healthy humans.
A 6-mo Human Study of Premonitory Symptoms of Dental Caries
The first human study using candies formulated with erythritol as the sole sweetener in healthy subjects was published in Caries Research in 2005 (Mäkinen et al. 2005) . Teenage subjects (~17 y of age, n = 136) were given candies (hard lozenges) containing xylitol, erythritol, or sorbitol to suck 6 times daily and underwent examinations (dental evaluations and sample collection of 736499A DRXXX10.1177/0022034517736499Advances in Dental ResearchOral-Systemic Health Roles of Erythritol research-article2017 1 DGH Nutrition Innovation, Keerbergen, Belgium plaque and saliva) just before the start of the intervention (baseline) and at 3 and 6 mo. They also were given toothpaste to use containing 34.5% of the corresponding polyol. Total daily exposure to each polyol was about 7 g: 6.5 g from the candies and 0.5 g from the toothpaste. An untreated control group (n = 30) was not given any candies and was asked to "continue their customary oral hygiene and dietary practice during the study." The groups showed no statistically significant differences with respect to age or caries experience at the start of the study. Compared to baseline, a statistically significant reduction was demonstrated in dental plaque weight as well as a reduction in the levels of Streptococcus mutans in dental plaque and saliva in the groups using erythritol or xylitol. Notably, the erythritol group had a significantly lower plaque weight compared not only to the untreated control (P < 0.05) but also to the sorbitol and xylitol groups (P < 0.05) after 6 mo.
Human 3-y Caries Study with a 3-y Follow-up Study
Results of a 3-y clinical caries study were published in Caries Research (Honkala et al. 2014) , as were the results of the 3-y follow-up study (Falony et al. 2016) . In this double-blind controlled study, 485 primary schoolchildren (~8 to 9 y old at baseline) were cluster randomized into 3 groups: erythritol (n = 165), xylitol (n = 156), and sorbitol (control, n = 164). Sorbitol as control in this study was based on the clinical data from Mäkinen et al. (2005) showing no differences in the sorbitol versus the untreated control group for the caries risk factor plaque fresh weight and plaque index as well in the plaque and saliva levels of mutans streptococci. Teachers provided the children with small candies (hard lozenges) containing erythritol, xylitol, or sorbitol (control) as the sole bulk sweetener to suck 3 times (at 08:00, 10:30, and 14:00) each school day (about 200 school days per year), resulting in a daily polyol consumption of about 7.5 g. The children received education on oral hygiene and diet at their annual examinations. They also were provided with a toothbrush and fluoride toothpaste every 6 mo with a recommendation to brush their teeth at least once a day. The children underwent clinical examinations at the start of the intervention (baseline) and at 12, 24, and 36 mo using the International Caries Detection and Assessment System (ICDAS II) (Ismail et al. 2007 ). For the follow-up study, children were examined 36 mo after termination of the intervention or 72 mo after baseline examinations. Over the 3-y intervention period, decayed, missing, and filled teeth/surfaces (DMFT/DMFS) indices in the mixed dentition did not differ between the intervention groups. However, the erythritol group had significantly fewer tooth surfaces developing into enamel or dentin caries and significantly less enamel caries tooth surfaces developing into dentin caries when compared with sorbitol ( Fig. 1a) . Furthermore, the time of enamel or dentin caries lesions to develop and dentin caries to progress was significantly longer in the erythritol group compared with the other polyol groups.
At the end of the intervention, the erythritol group had 143 fewer dental treatments (tooth restorations by a dentist) compared to control. Fresh dental plaque weight and counts of S. mutans in saliva and plaque, reported in a separate publication in the Journal of Dentistry (Runnel et al. 2013) , were lower in the erythritol group compared to the control (sorbitol) and xylitol groups. This lower plaque weight in the erythritol group (24% less compared to baseline) was consistent with the findings in the earlier mentioned 6-mo human study (Mäkinen et al. 2005 ) (30% less compared to baseline). Dental plaque in the erythritol group also showed lower levels of acetic, propionic, and lactic acid compared to control.
In addition to the clinical and biochemical parameters described, assessment of the impact of the sweeteners on salivary microbiome was determined by next-generation (Illumina) DNA sequencing. Saliva collected at the end of the 3-y intervention period showed that the impact of sorbitol and xylitol on the salivary microbiome composition was rather similar while different from that of erythritol ( Fig. 2) , with the latter having a higher relative abundance of the genera Veillonella, Streptococcus, and Fusobacterium and a lower relative abundance of Bergeyella (unpublished data). The erythritol group also had the lowest caries experience at the end of the 3-y intervention period (Honkala et al. 2014) .
As shown in Figure 1b , the caries-preventive effect of 3-y erythritol consumption compared to sorbitol could still be Figure 1 . Percentage of surfaces developing into enamel or dentin caries, enamel caries developing into dentin caries, any increase in caries score, and those that have been restored by a dentist according to the analysis of caries development over a 3-y intervention (a) and 3-y follow-up period (6 y in total) (b) in a child cohort (~7 to 8 y old at baseline, n = 485) consuming sorbitol-, erythritol-, or xylitol-containing tablets 7.5 g/d (3× per school day, 200 d/y). Adapted from Falony et al. (2016) . *P < 0.05, **P < 0.01, ***P < 0.001 compared to sorbitol using Fisher's exact test (2-tailed).
observed 3 y after termination of the intervention, although the differences were smaller (Falony et al. 2016) .
Mechanistic Studies of Erythritol Effects on Oral Health
The observed lower plaque weights and S. mutans counts in the erythritol group observed in the above human studies can explain the mechanism of action by which erythritol reduces the development of dental caries. Numerous in vitro studies provide further insight into such mechanisms. Mäkinen (2011) conducted in vitro tests with several strains of S. mutans in which 0.6 M erythritol, sorbitol, xylitol, or untreated media was incubated with the organism for up to 5 h. Erythritol inhibited growth more effectively compared with xylitol, sorbitol, and maltitol. On a weight basis, the gram amount of maltitol required to reduce growth is about 7 times higher compared to erythritol. For xylitol, it was about 3 times higher. In addition to its inhibition of the growth of S. mutans, other research demonstrated that erythritol decreased the adherence of polysaccharide-forming oral streptococci (14 strains tested: S. mutans [9] , Streptococcus sanguinis [2], Streptococcus salivarius [2] , and Streptococcus sobrinus [1] ) in an in vitro study that investigated growth inhibition and adherence of cells to a smooth glass surface in the presence of 2% or 4% erythritol or xylitol (Söderling and Hietala-Lenkkeri 2010) . Both erythritol and xylitol, at a concentration of 4%, significantly reduced the glass surface adhesion of most of the polysaccharide-forming streptococci tested. Growth inhibition was considered not to be associated with the magnitude of the decrease in adherence, indicating that cell adherence was via a mechanism that did not depend on growth inhibition. Another study suggested that, compared to xylitol, erythritol in low concentrations (0.5% to 2%) had a weaker inhibition effect on the bacterial growth and acid production of S. mutans while having stronger effect at high concentrations (8% to 16%) (Yao et al. 2009 ). The higher inhibition efficiency of erythritol compared to xylitol at higher concentrations was confirmed in other research (White et al. 2015) . In that study, strains of S. mutans and S. sobrinus were incubated with xylitol or erythritol for 48 h, and optical density was measured using confocal microscopy at 620 or 640 nm to determine bacterial growth. Both polyols inhibited growth completely: at 15% for erythritol and at 30% for xylitol. No synergistic or antagonistic effect was noted when the polyols were combined (White et al. 2015) . Further in vitro research also demonstrated greater inhibition of growth, adherence of bacteria, and formation of biofilm for erythritol compared to xylitol when 2% or 4% of each polyol was incubated with streptococci strains (S. mutans, S. sobrinus, or S. sanguinis) overnight in microtiter plates (Ghezelbash et al. 2012) . Similar inhibitory effects of erythritol at a concentration of 4% on S. mutans were also reported by Saran et al. (2015) , who observed 56.45% and 36.42% inhibition of growth and biofilm formation, respectively. Another biofilm study reported that 10% erythritol had an inhibitory effect on the microstructure and metabolomic profiles of biofilm composed of Porphyromonas gingivalis and Streptococcus gordonii and that the most effective reagent to reduce P. gingivalis accumulation onto S. gordonii substrata was erythritol compared to xylitol and sorbitol (Hashino et al. 2013 ). The authors suggested that erythritol's inhibitory effects function "via several pathways, including suppression of growth resulting from DNA and RNA depletion, attenuated extracellular matrix production, and alterations of dipeptide acquisition and amino acid metabolism." Another mechanistic study demonstrated that erythritol and xylitol inhibited the growth of S. mutans, reduced adhesion of S. mutans to smooth surfaces, and decreased the expression of genes involved in sucrose metabolism such as glucosyltransferase and fructosyltransferase (Park et al. 2014) .
Systemic Health Effects
Unlike other polyols, erythritol is readily and almost completely absorbed in the small intestine, not systemically metabolized to any significant degree, and excreted unchanged with the urine (Bernt et al. 1996; Munro et al. 1998 ). This unique metabolic profile renders erythritol unique systemic effects: it is noncaloric, noninsulinemic, and nonglycemic. In addition, it is well-tolerated, and due to its very high bioavailability, emerging research has shown potential for erythritol to provide cardiovascular benefits partly caused by the fact that it is capable of acting systemically as an antioxidant.
Effects of Erythritol on the Gastrointestinal Tract
Polyols are slowly digestible carbohydrates that are usually well tolerated when consumed in moderate amounts. They can, however, produce gastrointestinal distress and have a laxative effect when consumed in excessive amounts. The threshold differs for each polyol and depends greatly on its rate of absorption from the small intestine. Because polyols are poorly absorbed, the unabsorbed fraction will enter the large intestine and is typically fermented. When excessive amounts are consumed, a larger fraction will pass on to the colon and may exceed the fermentation capacity and act osmotically to produce a laxative effect (Lifschitz 2000) . As a 4-carbon polyol, erythritol's small molecular size allows it to be rapidly absorbed through passive diffusion. Studies in animals and humans have shown that approximately 90% of the ingested dose is absorbed from the small intestine and excreted in the urine unchanged (Munro et al. 1998 ). This level is substantially greater than the absorption of all other polyols; lactitol and isomalt are poorly absorbed (<10%), sorbitol and mannitol show about 15% to 25% absorption, and corresponding figures for maltitol and xylitol are 40% to 50% (Livesey 2003) . In addition, the small fraction of ingested erythritol that reaches the colon is not fermented (Arrigoni et al. 2005 ). This explains why erythritol is so well tolerated and does not cause osmotically-induced laxative effects under anticipated conditions of use. Digestive tolerance studies in adults and children, executed under the most stringent condition (bolus dose in a liquid on an empty stomach), have repeatedly demonstrated that the no observed effect level (NOEL) for laxation is at least 0.7 g per kg body weight, about 2 to 4 times higher compared to other polyols (Oku and Okazaki 1996; Storey et al. 2007; Jacqz-Aigrain et al. 2015) . The Table shows the NOEL for laxation of erythritol, xylitol, sorbitol, and fructose.
Many authorities, including the European Food Safety Authority (EFSA), confirmed this high NOEL for erythritol. The EFSA also confirmed that young children tolerate erythritol equally well as adults on a body weight basis (EFSA 2015) .
Effects of Erythritol on Cardiovascular Health
Erythritol is an excellent hydroxyl radical (OH . ) scavenger: it can cause a dose-dependent delay in hemolysis of red blood cells exposed to OH . radicals and prevent endothelial dysfunction in diabetic rats (den Hartog et al. 2010 ). Erythritol's high and relatively long systemic bioavailability supports these effects. Endothelial dysfunction contributes to the pathogenesis of cardiovascular disease in diabetes mellitus and predicts cardiovascular events (Flammer et al. 2012) . A human pilot study in 24 subjects with type 2 diabetes mellitus examined the systemic effects before and after acute (2 h) and chronic (4 wk) erythritol consumption on vascular function (Flint et al. 2013) . Acute erythritol improved endothelial function in small arteries, and chronic erythritol decreased central pulse pressure (47 ± 13 to 41 ± 9 mm Hg, P = 0.02). Hence, this study showed that erythritol consumption acutely improved small vessel endothelial function and that chronic consumption reduced central aortic stiffness. Mechanistic research in endothelial cells showed that erythritol could shift a variety of damage and dysfunction parameters to a safer side, thereby reversing the damaging effects of hyperglycemic conditions (Boesten et al. 2013) .
Discussion
Human studies and in vitro research show that erythritol effectively decreased weight of dental plaque and adherence of common streptococcal oral bacteria to tooth surfaces; inhibited growth and activity of caries-associated bacteria, including S. mutans; decreased expression of bacterial genes involved in sucrose metabolism; and reduced the overall incidence of dental caries as long as 3 y after termination of the intervention (Falony et al. 2016) . Most of the in vitro research that compared erythritol with xylitol and sorbitol on oral biofilm and microbes showed a high similarity in the mechanisms by which erythritol and xylitol reduced growth, acid production, glucosyland fructosyltransferase gene expression, and cell adhesion (sorbitol did not show such effects). Some mechanistic studies showed a higher efficacy of erythritol compared to xylitol (Mäkinen 2011; Ghezelbash et al. 2012; Hashino et al. 2013; Runnel et al. 2013; White et al. 2015) and some a similar efficacy (Söderling and Hietala-Lenkkeri 2010; Park et al. 2014) . Two human studies comparing the impact of erythritol, xylitol, and sorbitol on dental plaque weight showed that erythritol was more effective than sorbitol and xylitol at reducing dental plaque biomass (Mäkinen et al. 2005; Honkala et al. 2014 ). The only long-term (3 y) caries study to date comparing candies (hard lozenges) made with erythritol, xylitol, and sorbitol demonstrated a slower rate of caries development and lower caries incidence in the erythritol group compared to sorbitol and xylitol, as well as no difference between xylitol and sorbitol (Honkala et al. 2014) . At the end of the intervention, the erythritol group had 143 fewer dental treatments (tooth restorations by a dentist) compared to the sorbitol group, which is not only statistically but also clinically relevant. Some previous caries studies with xylitol in chewing gum showed a higher caries-preventive effect of xylitol compared to sorbitol (Mäkinen 2010) . The salivary stimulating effects of chewing gum are much higher compared to lozenges (Fig. 3 ) (Dawes and Macpherson 1992) . A quantitative systematic review of clinical trials comparing the caries-preventive effects of xylitol versus sorbitol concluded that the evidence is contradictory and identified salivary flow as one of the confounding factors (Mickenautsch and Yengopal 2012) . Another important difference that may explain the higher caries-preventive efficacy of erythritol over xylitol are their molecular weights of 122 and 152, respectively. This difference could favor erythritol in terms of a potentially higher diffusion speed and migration into dental plaque and also means that for the same effective mass or weight concentration, there are 24.6% more erythritol molecules compared to xylitol.
Systemic effect studies demonstrated that erythritol is readily absorbed, not systemically metabolized, and excreted with the urine. Due to this metabolic profile, it is noncaloric, nonglycemic, noninsulinemic, and well tolerated without gastrointestinal side effects under common use conditions. Erythritol has shown to efficiently scavenge hydroxyl radicals and prevent endothelial dysfunction in diabetic rats (den Hartog et al. 2010) . A human pilot study (Flint et al. 2013) provided evidence that erythritol has systemic favorable effects on small vessel endothelial vasodilator function, hypertension, and central aortic stiffness in people with diabetes mellitus. People with diabetes often try to replace most of the sugar they consume by sugar replacers. Erythritol is a welcome addition to this group of sugar replacers as it not only replaces unwanted effects of sugar in this subpopulation but may actually improve their vascular health status. Further studies are needed to confirm erythritol's impact on health outcomes.
In conclusion, food and oral care products formulated with erythritol can provide significant support in oral and systemic health. Erythritol has the highest digestive tolerance of all polyols and is well tolerated. When consumed, erythritol does not contribute any energy to the body and therefore is a helpful ingredient to support weight management. It can provide better tooth protection than sorbitol and xylitol, as demonstrated in human studies in children and teenagers. Erythritol also can potentially reduce the risk for endothelial dysfunction in people with diabetes. Erythritol may therefore be of importance as an oral care or dietary-based preventive strategy to help maintain oral and cardiovascular health over and above its weight management benefits when replacing sugar.
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